FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to the pharmaceutical industry, particularly to a composition for treating Helicobacter pylori. The pharmaceutical composition, which contains S-allyl-L-cysteine or its pharmaceutically acceptable salt, or their solvate, or their hydrate for preparing a therapeutic agent for Helicobacter pylori in preventing or treating gastrointestinal disorders which have Helicobacter pylori as a factor making a major contribution to the progression thereof. The pharmaceutical composition for Helicobacter pylori. The nutrient composition for Helicobacter pylori. Using S-allyl-L-cysteine or their pharmaceutically acceptable salt, or their solvate, or hydrate for preparing the therapeutic agent for Helicobacter pylori. Using S-allyl-L-cysteine or their pharmaceutically acceptable salt, or their solvate, or hydrate for preparing a nutritional composition for treating Helicobacter pylori.
EFFECT: compositions are effective for Helicobacter pylori in preventing or treating the gastrointestinal disorders.
14 cl, 18 dwg, 3 tbl, 7 ex
Title |
Year |
Author |
Number |
COMPOSITION FOR THE PREVENTION, TREATMENT OR ALLEVIATION OF GASTROINTESTINAL DISEASES, CONTAINING A CORYNEBACTERIUM STRAIN AND A PRODUCT OF ITS CULTIVATION |
2020 |
- Kim Yang-Su
- Lee Nahum
- Hong Young Gi
|
RU2806746C2 |
NOVEL ACID SECRETION INHIBITOR AND ITS USE |
2021 |
- Yun, Khon Chkhul
- Pak, Dzhun Te
- Li, Chzhun Vu
- An, Ken Mi
- Im, A Ran
- Chzhon, Vu Dzhin
- Kho, Chzhe Kho
- Khon, Chan Khi
- Pak, Chzhun Yn
- Son, Te Ik
- Khon, Da Khe
- Kim, Chzhun Kho
- Shin, Chzhe Y
- Yu, En Ran
- Chan, Min Van
- Chzhe, In Gyu
- Kan, Su En
- Son, Yun Sun
- Li, Dzhu Yun
|
RU2815697C1 |
COMPOSITIONS FOR PREVENTING OR RELIEVING GASTROINTESTINAL DISEASES |
2010 |
- Cho Il Khvan
- Kvon Okh Eok
- An Tae Kun
- Park Chi Khie
- Chung Joung Mee
- Choj Nak Khiun
- Sung Bo Khiun
- Kim Joung Riool
|
RU2500416C2 |
APPLICATION OF ALLYLAMINE DERIVATIVES, SUCH AS TERBINAPHIN, IN MANUFACTURING MEDICINAL PREPARATION FOR TREATING HELICOBACTER PYLORI INFECTION OR HELICOBACTER PYLORI-ASSOCIATED DISEASES |
1996 |
- Lindli Ajven Dzhejmz Dalton
- Rajder Nil Stjuart
|
RU2193402C2 |
METHOD OF OBTAINING HIGHLY PURIFIED ASIATICOSIDE COMPOSITION FROM Centella asiatica AND METHOD OF APPLICATION THEREOF |
2010 |
- Sunil Bkhaskaran
- Mokhan Vishvaraman
|
RU2565410C2 |
PEPTIDE PHARMACEUTICAL COMPOSITION, BASED DRUG FOR GASTRODUODENAL DISEASES CAUSED BY HELICOBACTER PYLORI, AND METHOD OF USING IT |
2011 |
- Khavinson Vladimir Khatskelevich
- Kvetnoj Igor' Moiseevich
- Poljakova Viktorija Olegovna
- Ryzhak Galina Anatol'Evna
- Kozlov Lenar Vasil'Evich
|
RU2449805C1 |
METHOD OF INDUCTION OF PROTECTIVE IMMUNE RESPONSE IN MAMMALS TO HELICOBACTER INFECTION, VACCINE FOR INDUCTION OF PROTECTIVE IMMUNE RESPONSE IN MAMMALS FOR HELICOBACTER INFECTION, METHOD OF INDUCTION OF PASSIVE PROTECTION IN MAMMALS AGAINST INFECTION WITH HELICOBACTER, AND METHOD OF ESTIMATION OF ENDOGENOUS IMMUNE RESPONSE IN MAMMALS INFECTED WITH HELICOBACTER |
1993 |
- P'Er Mishetti
- Andre Bljum
- Katrin Daven
- Rajner Khaas
- Iren Kortezi-Telaz
- Zhan-P'Er Krekhenbjul'
- Ehmilija Saraga
|
RU2125891C1 |
ANTI-HELICOBACTER AGENT AND METHOD FOR USE THEREOF |
2018 |
|
RU2713154C1 |
PHARMACEUTICAL COMPOSITION FOR TREATING DISORDERS INCLUDING GASTROINTESTINAL IRRITATION |
2009 |
- Bellinvia Sal'Vatore
- Martelli Laura
- Martelli Mario
|
RU2497527C2 |
DRUGS, SET AND A METHOD OF TREATMENT OF GASTROENTERIC DISEASES CAUSED OR MEDIATED BY INFECTION WITH HELICOBACTER PYLORI |
1992 |
- Ehndrju Aleksander Makkolm
|
RU2116071C1 |